Atlas Trials

Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712

Clinical trial NCT00805454 · COMPLETED

Trial details

NCT number
NCT00805454
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-12-01
Primary completion
2009-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.